Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/1995
06/28/1995EP0659193A1 Platelet aggregation inhibitors
06/28/1995EP0465556B1 Platelet specific immunoconjugates
06/28/1995EP0457758B1 Tissue plasminogen activator having zymogenic or fibrin specific properties
06/27/1995US5428182 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
06/27/1995US5428158 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/27/1995US5428046 Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments
06/27/1995US5428004 Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
06/27/1995US5427937 Hookworm anticoagulant
06/27/1995US5427918 Incubating plasminogen activator with fibrinogen degradation product containing methionine oxidized to sulfoxide; chromatography
06/27/1995US5427797 Anticoagulants; therapy for respiratory system disorders
06/22/1995WO1995016690A1 PYRANO[f]QUINOLINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
06/22/1995WO1995016687A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016661A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
06/22/1995WO1995016452A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
06/22/1995WO1995016437A1 Method of transmitting a biologically active material to a cell
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995WO1995009611A3 Stable protein: phospholipid compositions and methods
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2176247A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995CA2174729A1 A method of preventing depletion of non-autologous hematopoietic cells and animal model systems for use thereof
06/22/1995CA2138493A1 Methods of inhibiting thrombin
06/22/1995CA2138490A1 Methods of increasing thrombomodulin expression
06/22/1995CA2138100A1 Methods of treating menstrual symptoms and compositions therefor
06/21/1995EP0658585A2 Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants
06/21/1995EP0658569A1 Method for decoloring human serum albumin
06/21/1995EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins
06/21/1995EP0658206A1 Inhibitor resistant serine proteases
06/21/1995EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
06/21/1995EP0658107A1 Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
06/20/1995US5426119 Thromboxane antagonists
06/20/1995US5426098 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
06/20/1995US5426031 Extraction methods for preparing thromboplastin reagents
06/20/1995US5425936 Useful for therapeutic, prophylactic and diagnostic purposes
06/18/1995CA2138349A1 Method for decoloring human serum albumin
06/15/1995WO1995016209A1 Process for the production of combinatorial compound libraries
06/15/1995WO1995016030A1 Purification of vitamin-k dependent proteins by membrane chromatography
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2175078A1 Process for the production of combinatorial compound libraries
06/15/1995CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657426A2 Tricyclic pyrrole derivatives
06/14/1995EP0656889A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
06/14/1995EP0656777A1 Ready-to-inject azosemide solutions.
06/13/1995US5424456 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424313 Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives
06/13/1995US5424302 Process for the production of starch degradation products with a narrow molecular weight distribution
06/13/1995US5424293 Phenylimidazolidine derivatives and their use
06/13/1995US5424291 Isosteric peptides
06/13/1995US5424057 Medical diagnosis
06/08/1995WO1995015373A2 Inhibition of dna methyltransferase
06/08/1995WO1995015343A1 POLY-β-1→4-N-ACETYLGLUCOSAMINE
06/08/1995WO1995015336A1 Double-chain hemoregulatory peptides
06/08/1995WO1995015183A1 Hirudin conjugates from hirudin and lipophilic compounds
06/08/1995WO1995015165A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
06/08/1995WO1995002054A3 Platelet glycoprotein v gene and uses
06/08/1995DE4437502A1 Conjugates of hirudin with lipophilic cpds.
06/08/1995DE4421433C1 Transdermal therapeutic system for treatment of, e.g., hypertension
06/08/1995CA2177822A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
06/08/1995CA2177031A1 Inhibition of dna methyltransferase
06/08/1995CA2176967A1 Hirudin conjugates from hirudin and lipophilic compounds
06/07/1995EP0656366A1 Iron-lactoferrin combination and process for producing the same
06/07/1995EP0656354A1 Substituted N-piperidino 3-pyrazolecarboxamide
06/07/1995EP0656348A2 Aceric acid derivatives as medicaments
06/07/1995EP0656061A1 Novel glycoforms of soluble complement receptor 1
06/07/1995EP0656008A1 Thrombin receptor antagonists
06/07/1995EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
06/07/1995EP0655925A1 Anti-cancer therapeutic compositions containing whey protein concentrate
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655888A1 Production of human hemoglobin in transgenic pigs
06/07/1995CN1028757C Process for preparing heterocyclic derivatives
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422351 Antiallergens; antiinflammatory agents
06/06/1995US5422249 Process for the manufacture of thrombin inhibitors
06/06/1995CA1335816C 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives
06/06/1995CA1335788C Protein absorption enhancing agents
06/01/1995WO1995014785A1 Composition for the in vivo production of therapeutic products
06/01/1995WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
05/1995
05/31/1995EP0655462A1 Linear adhesion inhibitors
05/31/1995EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655440A2 1-Aminoethylindoles
05/31/1995EP0655439A2 5,6-Bicyclic glycoprotein IIb IIIa antagonists useful in inhibition of platelet aggregation
05/31/1995EP0655089A1 Effects of actin filaments on fibrin clot structure and lysis
05/31/1995EP0655060A1 Pharmaceutically active diketopiperazines
05/30/1995US5420310 Conversion of 15-beta to 15-alpha 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives
05/30/1995US5420252 For treatment of thrombotic disorders
05/30/1995US5420247 Genetic engineering and expression vectors
05/30/1995US5420019 Stable bactericidal/permeability-increasing protein muteins
05/30/1995CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof
05/26/1995WO1995014038A2 Purification of hemoglobin
05/26/1995WO1995014025A1 Piperidinylcamphorsulfonyl oxytocin antagonists
05/26/1995WO1995014008A1 Substituted 5-ring heterocycles, their preparation and their use
05/26/1995WO1995013825A1 TRANSDERMAL COMPOSITION OF N-[N-[5-[4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-α-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
05/26/1995CA2176462A1 Transdermal composition of n-¬n-¬5-¬4-(aminoiminomethyl)phenyl|-1-oxopentyl|-l-.alpha.-aspartyl|-l-phenylalanine or its esters and their pharmaceutically acceptable salts
1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 671